Artificial Intelligence Predicts Future Pancreatic Cancer
An artificial intelligence tool has successfully identified those at the highest risk for pancreatic cancer up to 3 years before diagnosis.
Read MorePosted by Chris Wolski | May 18, 2023 | Pancreatic |
An artificial intelligence tool has successfully identified those at the highest risk for pancreatic cancer up to 3 years before diagnosis.
Read MorePosted by Tonya Manning | May 15, 2023 | Podcasts |
In this episode of Clinical Lab Chat, Chris Wolski and his guest, medical lead at Hurdle, Alex Owens, MD, MPH, discuss the reasons for the rise of at-home testing during COVID, how at-home testing improves healthcare access, and the win-win-win it brings to clinical laboratories.
Read MorePosted by Melanie Hamilton-Basich | May 10, 2023 | Kidney Disease |
Healthy.io is launching a program with Boehringer Ingelheim that will support at-home testing for patients at risk of chronic kidney disease.
Read MorePosted by Chris Wolski | Apr 21, 2023 | Diabetes & Metabolic Diseases, Lab Automation |
Digital Diagnostics, an artificial intelligence diagnostic health care company, has expanded into lab settings in the Southeastern U.S.
Read MorePosted by Chris Wolski | Apr 19, 2023 | Diabetes & Metabolic Diseases, POC Instruments |
Orange Biomed is currently conducting studies of a rapid A1c, a glycated hemoglobin analyzer through single-cell analysis of red blood cells.
Read More